Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@genomics-online.com

Human HOXD10 siRNA Oligo

RNAi HOXD10 Species: Human HPLC purified
OriGene
Catalog No. ABIN3341996
Supplier Product No.: sr302213
$512.82
Plus shipping costs $50.00
1 kit
Shipping to: United States
Delivery in 4 to 8 Business Days

Quick Overview for Human HOXD10 siRNA Oligo (ABIN3341996)

Gene

HOXD10 (Homeobox D10 (HOXD10))

Species

Human

Application

RNA Interference (RNAi)

Purification

HPLC purified
  • Supplier Product No.

    sr302213

    Supplier

    OriGene

    Oligo-Type

    siRNA Oligo

    Purpose

    siRNA (27 mer) kit with 3 gene-specific unique siRNA duplexes and negative control for gene knockdown.

    Brand

    Trilencer-27

    Sequence

    Available with shipment

    Components

    • HOXD10 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each
    • Trilencer-27 Universal Scrambled Negative Control siRNA Duplex - 2 nmol
    • RNAse free siRNA Duplex Resuspension Buffer - 2 ml
  • Application Notes

    • No. of transfections: Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM)
    • Quality Control: Tested by ESI-MS

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    • 2 nmoles of each duplex is provided (including the control duplex). Addition of 100 μL of RNase-free Duplex Buffer will result in 20 μM final concentration, vortex thoroughly and microfuge prior to use.
    • Heat to 94 °C for 2 minutes, remove from heat and allow tube to cool to room temperature. The oligos were dried in duplex form so heating may not be necessary, however following this protocol ensures that the contents will be fully duplexed.

    Storage

    -20 °C

    Storage Comment

    The dried duplexes can be stored at 4 °C. However, once reconstituted with dH2O, the plasmids must be stored at -20°C.

    Expiry Date

    12 months
  • Hakami, Darda, Stafford, Woll, Lambert, Hunter: "The roles of HOXD10 in the development and progression of head and neck squamous cell carcinoma (HNSCC)." in: British journal of cancer, Vol. 111, Issue 4, pp. 807-16, (2014) (PubMed).

  • Target

    HOXD10 (Homeobox D10 (HOXD10))

    Alternative Name

    HOXD10
You are here: